Non-invasive Prenatal Test - Panorama or NIPT
We offer two types of Non-invasive Prenatal Tests, Panorama and NIPT.
For afternoon and Saturday appointments please use this booking link:
What is Panorama?
Panorama is a non-invasive DNA screening test that can tell you important information about your pregnancy, as early as nine weeks of gestation. With Panorama, you can find out for the likelihood of your baby having a chromosomal abnormality, such as Down syndrome, and all that’s required is a sample of your blood. If you so choose, you may also find out the gender of your baby.
Get essential genetic information about your baby as early as nine weeks into your pregnancy with the Panorama™ Prenatal Screen.
• Screens for genetic abnormalities
• Determines the baby’s gender
• Done in a single, in-office visit
• Brings no risk to your baby
Safe and Accurate
Panorama is a non-invasive and highly accurate prenatal screening test that gives you vital information about your baby’s health.
Find out more:
What is Panorama?
Panorama® is the only non-invasive prenatal screening test that distinguishes between fetal and maternal cell-free DNA thanks to SNP-based sequencing and Natera's proprietary algorithm. Using advanced bioinformatics techniques, Panorama screens for a broad panel of chromosomal conditions, including:
Chromosome Abnormalities:
• Trisomy 21 (Down syndrome)
• Trisomy 18 (Edwards syndrome)
• Trisomy 13 (Patau syndrome)
• Triploidy
Sex Chromosome Abnormalities:
• Monosomy X (Turner syndrome)
• Klinefelter syndrome
• Triple X syndrome
• XYY syndrome
Microdeletions:
• 22q11.2 deletion syndrome
• 1p36 deletion syndrome
• Prader Willi syndrome
• Angelman syndrome
• Cri-du-chat syndrome
• Gender of the Baby (optional)
Illumina Veriseq
Non-invasive prenatal testing (NIPT) can identify a pregnancy in which the baby is likely to have a chromosome condition. These conditions are uncommon, do not usually run in the family, and can happen in any pregnancy.
NIPT can be requested by your doctor from 10 weeks’ gestation and we recommend that your doctor arrange for you to have an ultrasound to confirm your gestation, prior to taking your blood sample. Collecting a mother’s blood sample for NIPT poses no threat to the fetus.
Our NIPT routinely screens for these chromosome conditions:
- Down syndrome (trisomy 21)
- Edwards syndrome (trisomy 18)
- Patau syndrome (trisomy 13)
You also have the option to determine the sex of your baby. The test can be performed from 10 weeks of pregnancy.
According to the International Society for Prenatal Diagnosis (ISPD), non-invasive prenatal testing, including Panorama, is appropriate as a primary screening test for pregnant women of all ages. Down syndrome and certain other chromosomal conditions occur more frequently in babies born to mothers over 35 years old. Other conditions for which Panorama screens – such as microdeletion syndromes – occur with the same frequency in babies, regardless of the mother’s age.
Currently, Panorama cannot be used in the following types of pregnancies:
• Multiple gestation pregnancies
• Pregnancies that are using an egg donor or a surrogate
• Pregnant women who are bone marrow transplant recipients
During pregnancy, some of the DNA from the baby crosses into mom’s bloodstream. DNA is organized in structures known as chromosomes, which carry the baby’s genetic information. Panorama uses a blood sample from the mother to analyze the baby’s DNA for certain chromosomal conditions that could affect the baby’s health.
Panorama is a non-invasive prenatal test (NIPT). This means that Panorama is safe for you and your baby. To have the test done, your healthcare provider just draws a sample of blood from your arm. The sample is then sent to a lab for processing.
Many pregnant women want to know about the health of their baby. If you would like information about your baby’s health, talk with your healthcare provider. He or she will advise you as to what tests you might want to have to help give you peace of mind.
The Panorama prenatal screen is designed for women of any age and ethnicity who are at least 9 weeks pregnant. It cannot currently be used by women who are carrying more than one baby (twins or triplets), women who have used a donor egg or a surrogate, or those who have received a bone marrow transplant.
Some women have a higher chance for chromosomal abnormalities because of their age, family history or other screening test results. However, certain conditions such as the microdeletions that are on Panorama’s panel affect women of all ages at the same rate. Regardless of your age or family or reproductive history, Panorama can help determine your baby’s risk of being affected with a chromosome condition.
Currently, the test screens for:
• Trisomy 21: This is caused by an extra copy of chromosome 21 and is also called Down syndrome. This is the most common cause of intellectual disability. It may also cause certain birth defects of the heart or other organs and may cause hearing or vision problems.
• Trisomy 18: This is caused by an extra copy of chromosome 18 and is also called Edwards syndrome. This causes severe intellectual disability. It also causes serious birth defects of the heart, brain and other organs. Babies with Edwards syndrome usually pass away before one year of age.
• Trisomy 13: This is caused by an extra copy of chromosome 13 and is also called Patau syndrome. This causes severe intellectual disability. It also causes many serious birth defects. Babies with Patau syndrome usually pass away before one year of age.
• Monosomy X (also called Turner syndrome or 45, X): This is caused by a missing X chromosome and affects only girls. Girls with Monosomy X may have heart defects, hearing problems, minor learning disabilities and are usually shorter than average. As adults, they are often infertile.
• Triploidy: This condition is caused by having an extra set of 23 chromosomes (for a total of 69) and is associated with severe birth defects. A triploid pregnancy can cause serious complications for the mother, such as excessive bleeding after delivery and a risk of developing cancer. Babies with triploidy rarely make it to term and those that do usually pass away within a few months after delivery. It is important for the doctor to know about triploidy even if the mother miscarries so that she can be monitored for complications.
• Klinefelter syndrome: This is caused by an extra copy of the X chromosome, is also known as 47, XXY and only affects boys. Boys with Klinefelter syndrome may have learning disabilities, tend to be taller than average, and most men with this condition are infertile.
• Triple X syndrome: This is caused by an extra copy of the X chromosome, is also known as 47, XXX and only affects girls. Some girls with triple X syndrome have learning disabilities, some have emotional problems and most are taller than average.
• XYY syndrome: This is caused by an extra copy of the Y chromosome, is also known as 47, XYY and only affects boys. Boys with this condition tend to be taller than average and may have associated mild learning and behavioral difficulties.
• Panorama also screens for five microdeletion syndromes.
A small, missing (or “deleted”) piece of a chromosome is called a microdeletion. Unlike Down syndrome, which occurs more frequently in mothers who are 35 and older, microdeletions occur in pregnancies at the same rate for mothers of any age.
In many cases, there are no obvious ultrasound abnormalities that would suggest the fetus has a microdeletion. While many microdeletions have little impact on a child’s health and life, there are some that can cause intellectual disabilities and birth defects. Panorama screens for five microdeletions, all of which can be associated with serious health issues:
• 22q11.2 deletion syndrome / DiGeorge syndrome (occurs in about 1 in 2,000 births) Babies born with 22q11.2 deletion syndrome often have heart defects, immune system problems, and mild-to-moderate intellectual disability. They may also have kidney problems, feeding problems, and/or seizures. Up to 25% of individuals with this syndrome develop schizophrenia in adulthood.
• 1p36 deletion syndrome (occurs in about 1 in 5,000 births)
Babies born with 1p36 deletion syndrome have weak muscle tone, heart and other birth defects, intellectual disabilities, hearing loss and behavior problems. About half will have seizures.
• Angelman syndrome (occurs in about 1 in 12,000 births)
Babies born with Angelman syndrome often have delayed milestones (like sitting, crawling and walking), seizures, and problems with balance and walking. They also have a severe intellectual disability and most do not develop speech.
• Cri-du-chat syndrome, also known as 5p minus (occurs in about 1 in 20,000 births) Babies born with Cri-du-chat syndrome typically have low birth weight, small head size, and decreased muscle tone. Feeding and breathing difficulties are also common. They have a moderate-to-severe intellectual disability.
• Prader-Willi syndrome (occurs in about 1 in 10,000 births)
Babies born with Prader-Willi syndrome have low muscle tone and problems with feeding and gaining weight. They also have intellectual disability. As children and adults, they have rapid weight gain and often develop obesity-related medical problems.
Panorama is not the only screening test available during pregnancy. Older screening tests that measure hormones in a pregnant woman’s blood (called maternal serum screening tests) can also tell you if there is a high chance your baby has a chromosomal condition, such as Down syndrome. Maternal serum screening tests are less accurate than Panorama*. This means that serum screening tests are more likely than Panorama to miss certain chromosomal conditions and more likely than Panorama to indicate an abnormal chromosomal condition when none actually exists.
Panorama is a screening test; it is not a diagnostic procedure. This means that test results from Panorama only alert you of the likelihood that your baby has a chromosomal condition. To diagnose the baby – and know with certainty if the baby has a chromosomal condition – invasive diagnostic tests, such as chorionic villus sampling (CVS) or amniocentesis, can be done. Both of these tests have risks, including the small chance of miscarriage.
Speak with your healthcare provider if you have more questions about your testing options.
